|
India News Releases
|
(India.CityRegions.Com, December 20, 2016 ) Melasma is a common skin problem. The condition causes dark, discolored patches on your skin. The dark patches in melasma could be triggered by several factors, including pregnancy, birth control pills, hormone replacement therapy (HRT and progesterone), family history of melasma, race, antiseizure medications, and other medications that make the skin more prone to pigmentation after exposure to ultraviolet (UV) light.
Report Highlights:
This report Pharmaceutical and Healthcare latest pipeline guide Melasma (Chlosma) - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Melasma (Chlosma) (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Melasma (Chlosma) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Melasma (Chlosma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 2, 1 and 2 respectively.Melasma (Chlosma). Melasma (Chlosma) (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/melasma-chlosma-pipeline-review-h2-2016
Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Melasma (Chlosma) (Dermatology). - The pipeline guide reviews pipeline therapeutics for Melasma (Chlosma) (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Melasma (Chlosma) (Dermatology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Melasma (Chlosma) (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Melasma (Chlosma) (Dermatology)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001485310/sample
Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Melasma (Chlosma) (Dermatology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Melasma (Chlosma) (Dermatology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline. Key Companies profiles EpiPharm AG Hyundai Pharmaceutical Co Ltd RXi Pharmaceuticals Corp
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001485310/discount
List of Tables
Number of Products under Development for Melasma (Chlosma), H2 2016 6 Number of Products under Development by Companies, H2 2016 7 Comparative Analysis by Clinical Stage Development, H2 2016 8 Comparative Analysis by Early Stage Development, H2 2016 9 Products under Development by Companies, H2 2016 10 Melasma (Chlosma) - Pipeline by EpiPharm AG, H2 2016 11 Melasma (Chlosma) - Pipeline by Hyundai Pharmaceutical Co Ltd, H2 2016 12 Melasma (Chlosma) - Pipeline by RXi Pharmaceuticals Corp, H2 2016 13 Assessment by Monotherapy Products, H2 2016 14 Number of Products by Stage and Target, H2 2016 16 Number of Products by Stage and Mechanism of Action, H2 2016 18 Number of Products by Stage and Route of Administration, H2 2016 20 Number of Products by Stage and Molecule Type, H2 2016 22 Melasma (Chlosma) - Dormant Projects, H2 2016 28
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|